Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBS2320 for idiopathic pulmonary fibrosis
2023-504418-30-00Phase 2Completed
- Sponsor
- Modern Biosciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) comparing MBS2320 with Placebo (2 arms). Started Oct 2023; status: completed.
02
Drugs
Leramistat
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2023-504418-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504418-30-00.